Prospective alpha allocation in the clarification of optimal anticoagulation through genetics (COAG) trial.
- Published in:
- Clinical Trials, 2010, v. 7, n. 5, p. 597, doi. 10.1177/1740774510381285
- Publication type:
- Article
Works matching IS 17407745 AND DT 2010 AND VI 7 AND IP 5
Results: 13
1
2
Floor Discussion II.
- Published in:
- Clinical Trials, 2010, v. 7, n. 5, p. 608, doi. 10.1177/1740774510380507
- Publication type:
- Article
3
Floor Discussion I.
- Published in:
- Clinical Trials, 2010, v. 7, n. 5, p. 605, doi. 10.1177/1740774510380505
- Publication type:
- Article
4
Proceedings of the University of Pennsylvania annual conference on statistical issues in clinical trials: statistical issues in developing targeted therapies.
- Published in:
- Clinical Trials, 2010, v. 7, n. 5, p. 513, doi. 10.1177/1740774510380504
- Publication type:
- Article
5
Closing discussion.
- Published in:
- Clinical Trials, 2010, v. 7, n. 5, p. 611, doi. 10.1177/1740774510380503
- Publication type:
- Article
6
A threshold sample-enrichment approach in a clinical trial with heterogeneous subpopulations.
- Published in:
- Clinical Trials, 2010, v. 7, n. 5, p. 537, doi. 10.1177/1740774510378695
- Publication type:
- Article
7
Statistical considerations in evaluating pharmacogenomics-based clinical effect for confirmatory trials.
- Published in:
- Clinical Trials, 2010, v. 7, n. 5, p. 525, doi. 10.1177/1740774510375455
- Publication type:
- Article
8
Bayesian adaptive randomization designs for targeted agent development.
- Published in:
- Clinical Trials, 2010, v. 7, n. 5, p. 584, doi. 10.1177/1740774510373120
- Publication type:
- Article
9
A Bayesian adaptive design with biomarkers for targeted therapies.
- Published in:
- Clinical Trials, 2010, v. 7, n. 5, p. 546, doi. 10.1177/1740774510372657
- Publication type:
- Article
10
The efficiency of clinical trial designs for predictive biomarker validation.
- Published in:
- Clinical Trials, 2010, v. 7, n. 5, p. 557, doi. 10.1177/1740774510370497
- Publication type:
- Article
11
The mean does not mean as much anymore: finding sub-groups for tailored therapeutics.
- Published in:
- Clinical Trials, 2010, v. 7, n. 5, p. 574, doi. 10.1177/1740774510369350
- Publication type:
- Article
12
Predictive biomarker validation in practice: lessons from real trials.
- Published in:
- Clinical Trials, 2010, v. 7, n. 5, p. 567, doi. 10.1177/1740774510368574
- Publication type:
- Article
13
Clinical trials for predictive medicine: new challenges and paradigms.
- Published in:
- Clinical Trials, 2010, v. 7, n. 5, p. 516, doi. 10.1177/1740774510366454
- Publication type:
- Article